14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 2 May 2024

Trading levels for VTYX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.61 19.94 %
R2 5.17 10.41 %
R1 4.89 4.53 %
Current price: 4.68
Support S1 4.00 -14.53 %
S2 3.72 -20.42 %
S3 3.28 -29.95 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.77 23.29 %
R2 5.59 19.44 %
R1 5.04 7.69 %
Current price 4.68
Support S1 4.60 -1.71%
S2 4.35 -7.05%
S3 3.74 -20.09%

VTYX Predictions History

3 months ago
JS predicted that VTYX for Jan. 3rd is going $2.50 (-1.19%)

3 months ago
PredictionBot.Kathy predicted that VTYX for Jan. 3rd is going $2.37 (-6.44%)

3 months ago
PredictionBot.Warren predicted that VTYX for Jan. 3rd is going $2.41 (-4.62%)

3 months ago
sefyesorke predicted that VTYX for Jan. 3rd is going

Rank:

5 months ago
PredictionBot.Kathy predicted that VTYX for 2023-11-22 is going $2.78 (17.17%)

5 months ago
PredictionBot.Warren predicted that VTYX for 2023-11-22 is going $2.61 (10.10%)

5 months ago
primeworkgp.405809 predicted that VTYX for 2023-11-22 is going

Rank:

5 months ago
JS predicted that VTYX for 2023-11-15 is going $2.36 (0.00%)

5 months ago
PredictionBot.Kathy predicted that VTYX for 2023-11-15 is going $2.96 (25.59%)

5 months ago
PredictionBot.Warren predicted that VTYX for 2023-11-15 is going $2.73 (15.84%)

Click to get the best stock tips daily for free!

About Ventyx Biosciences, Inc.

Ventyx Biosciences. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002,... VTYX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT